EMBECTA CORP. - COMMON

embecta Announces Quarterly Cash Dividend

20 Dec 2022 05:00:00 By Nasdaq GlobeNewswire

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

14 Dec 2022 16:00:00 By Nasdaq GlobeNewswire

Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes

07 Nov 2022 05:50:00 By Nasdaq GlobeNewswire

embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results

03 Nov 2022 16:00:00 By Nasdaq GlobeNewswire

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

01 Nov 2022 05:50:00 By Nasdaq GlobeNewswire

embecta to Participate in Upcoming Investor Conferences in September

18 Aug 2022 16:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Third Quarter Fiscal 2022 Financial Results

15 Aug 2022 05:30:00 By Nasdaq GlobeNewswire

embecta Announces Inaugural Quarterly Cash Dividend

15 Aug 2022 05:00:00 By Nasdaq GlobeNewswire

embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022

05 Jul 2022 16:00:00 By Nasdaq GlobeNewswire

Embecta Corp. Reports Second Quarter and First Six Months of Fiscal Year 2022 Financial Results and Provides Financial Guidance for the Last Six Months of Fiscal Year 2022

13 May 2022 05:30:00 By Nasdaq GlobeNewswire

embecta to Participate in Upcoming Investor Conferences in May

09 May 2022 15:05:01 By Nasdaq GlobeNewswire

embecta Announces Second Quarter 2022 Earnings Conference Call Information

19 Apr 2022 05:50:00 By Nasdaq GlobeNewswire

embecta completes spin-off from BD and lists on NASDAQ as a global leader in diabetes care

01 Apr 2022 05:50:00 By Nasdaq GlobeNewswire